Hypothesized binding models for pirtobrutinib and covalent BTK inhibitor. (A) We hypothesize that pirtobrutinib stabilizes BTK in a closed, inactive conformation, whereas (B) cBTKi binding destabilizes the closed conformation, providing upstream kinase access to phosphorylate Y551. (C) A cartoon representation showing the domain organization of BTK.